Yunnan Botanee Bio Technology Group 2024 Q3 Quarterly Report

Quarterly Report 2024 Q3 of Yunnan Botanee Bio-Technology Group Co., Ltd. 1 Stock Code: 300957 Stock Abbreviation: Botanee Announcement No.: 2024- 053 Yunnan Botanee Bio-Technology Group Co., Ltd. 2024 Q3 Quarterly Report Botanee and all members of the Board of Directors guarantee that the information disclosed herein is true, accurate and complete without false hoods, misleading statement s or major omissions. Notices: 1. Botanee’s Board of Directors, Board of Supervisors, as well as directors, supervisors and senior management officers guarantee that the present quarterly report is true, accurate and complete without false hoods, misleading statements or major omissions, and undertake individual and joint legal liabilities arising therefrom. 2. Botanee’s legal representative Mr. Guo Zhenyu, CFO Mr. Wang Long, and Head of Accounting Department Mr. Liu Zhaofeng hereby declare that the financial information herein is authentic, accurate, and complete. 3. Whether this Q3 report has been audited or not: □ Yes No Quarterly Report 2024 Q3 of Yunnan Botanee Bio-Technology Group Co., Ltd. 2 I. Key financial data (i) Major Accounting Data and Financial Indicators Whether the Company needs to retrospectively adjust or restate the accounting data for the previous years □ Yes  No This Reporting Period Change in the Reporting Period (%) From the beginning of the year to the end of the Reporting Period Change in the period from the beginning of the year to the end of the Reporting Period(%) Operating revenue(RMB) 1,213,087,219.34 14.04% 4,017,760,019.31 17.09% Net profit attributable to shareholders of the listed companies (RMB) -68,999,289.50 -153.41% 414,768,732.22 -28.39% Net profit attributable to shareholders of the listed company after deducting non-recurring Gains and Losses (RMB) -78,224,976.78 -158.23% 341,368,837.06 -32.81% Net cash flows from operating activities (RMB) 6,430,018.31 -94.83% Basic earnings per share (RMB/share) -0.16 -151.61% 0.99 -27.74% Diluted earnings per share (RMB/share) -0.16 -153.33% 0.98 -27.94% Weighted average ROE -1.16% Decrease by 3.41 percentage points 7.07% Decrease by 3.11 percentage points End of the reporting period End of the Previous Year Change in the End of This Reporting Year over the End of the Previous Year (%) Total assets (RMB) 7,804,443,170.41 7,506,930,342.79 3.96% Owners' equity attributable to shareholders of listed companies (RMB) 5,903,907,588.93 5,860,994,371.02 0.73% Whether the Company’s share capital has changed and affected the amount of shareholders’ equity due to secondary public offering,placement; allotment; ESOP exercise , buybacks and other reasons from the end of the reporting period to the disclosure date of the quarterly report. Yes □No Current reporting period Beginning of year to end of reporting period Dividends for Preferred Shares That Have Been Paid ( RMB) Interest Paid on Perpetual Bonds ( RMB) Fully Diluted Dividends per Share Based on Latest

立即下载
综合
2024-10-25
22页
0.76M
收藏
分享

Yunnan Botanee Bio Technology Group 2024 Q3 Quarterly Report,点击即可下载。报告格式为PDF,大小0.76M,页数22页,欢迎下载。

本报告共22页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
本报告共22页,只提供前10页预览,清晰完整版报告请下载后查看,喜欢就下载吧!
立即下载
水滴研报所有报告均是客户上传分享,仅供网友学习交流,未经上传用户书面授权,请勿作商用。
相关图表
可比公司估值表
综合
2024-10-24
来源:前三季度归母净利润增长11.79%,持续丰富产品管线储备
查看原文
爱美客盈利预测主要调整项目
综合
2024-10-24
来源:前三季度归母净利润增长11.79%,持续丰富产品管线储备
查看原文
爱美客单季度营业收入及增速(亿元、%)图2:爱美客单季度归母净利润及增速(亿元、%)
综合
2024-10-24
来源:前三季度归母净利润增长11.79%,持续丰富产品管线储备
查看原文
可比公司估值表
综合
2024-10-24
来源:三季度收入受量价承压下滑22.5%,关注后续产能投产放量
查看原文
盈利预测主要调整项
综合
2024-10-24
来源:三季度收入受量价承压下滑22.5%,关注后续产能投产放量
查看原文
公司存货周转天数及应收账款周转天数图6:公司单季度现金流情况
综合
2024-10-24
来源:三季度收入受量价承压下滑22.5%,关注后续产能投产放量
查看原文
回顶部
报告群
公众号
小程序
在线客服
收起